Results 171 to 180 of about 2,782,099 (278)

New therapeutic options for metabolic‐associated steatotic liver disease

British Journal of Clinical Pharmacology, Volume 92, Issue 11, Page 3770-3777, November 2026.
An increasing number of patients are being diagnosed with metabolic dysfunction‐associated steatotic liver disease (MASLD). MASLD results from disturbances in hepatic lipid metabolism and is associated with an increased risk of cirrhosis and hepatocellular carcinoma and significant extrahepatic morbidity, including cardiovascular disease and ...
Tessa Straatmijer, Midas Mulder
wiley   +1 more source

Experimental methods in chemical engineering: Cyclic voltammetry—CV

The Canadian Journal of Chemical Engineering, Volume 104, Issue 11, Page 5776-5827, November 2026.
Abstract Cyclic voltammetry (CV) is a foundational electroanalytical technique for investigating redox behaviour and evaluating material performance across fields such as molecular electrochemistry, electrocatalysis, sensing, and energy storage. Despite its widespread use, a gap remains between formal electrochemical theory and the practical data ...
Yasser Matos‐Peralta, Christopher Panaritis, JoElen Hagler, Clara Santato, Gregory S. Patience   +4 more
wiley   +1 more source

Gene‐Guided Therapy in Type 2 Diabetes Mellitus: An Integrative Review of the Pharmacogenetics of Metformin and Sodium‐Glucose Cotransporter‐2 Inhibitors

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 6, November 2026.
Genetic variation influences the pharmacological response to metformin and SGLT2 inhibitors in patients with type 2 diabetes mellitus. Pharmacogenetic biomarkers affecting drug transport, metabolism and target activity contribute to inter‐individual differences in treatment efficacy and adverse effects, supporting the implementation of personalized ...
Imran Hossain, Mahnoor Haidar, Mahfuj Ahmed Ratul, Jannatul Ferdous Sumona, Sraboni Shabnaz, Abul Fojal Nokib, Fatema‐Tuz‐Zohora   +6 more
wiley   +1 more source

Efficacy and Safety of Oral Non‐Statin Lipid‐Lowering Therapies in Dyslipidaemia: A Systematic Review and Network Meta‐Analysis

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 6, November 2026.
A network meta‐analysis of 43 randomized trials showed that oral combination therapies, particularly obicetrapib plus ezetimibe and bempedoic acid plus ezetimibe, achieved the greatest LDL‐C reduction with reassuring safety profiles, supporting their use as effective oral alternatives for patients with dyslipidaemia. ABSTRACT Introduction Dyslipidaemia
Tamer Hodrob, Reem J. Saad, Aya Hamdy, Mariam Saleh Alheneedy, Ahmed Mohamed Shehata Abdelfattah Elsayed, Elsaghir Ghazy, Hazem Ayesh   +6 more
wiley   +1 more source

Probiotic-Postbiotic Synergy and Microbial Co-Culture Strategies for Hyperuricemia: Gut Microbiota and Functional Food Perspectives. [PDF]

Foods
Khawlah A, Zheng X, Jia Y, Wang Z, Yang Z.   +4 more
europepmc   +1 more source

Multiwalled Carbon Nanotube/Carbon Paste‐Modified Graphite Sheet Electrode Using Uric Acid as a Naturally Occurring Redox‐Active Molecule for Aptamer‐Mediated Signal Transduction

Electroanalysis, Volume 38, Issue 11, November 2026.
This study examines the use of uric acid (UA), a naturally occurring redox‐active molecule, as a reporter for aptamer‐mediated electrochemical signal transduction. Five graphite‐sheet electrode configurations were compared, with the multiwalled carbon nanotube/carbon paste‐modified graphite sheet electrode (MWCNT/CP/GSE) providing the strongest overall
Jixin Shang, Zhuoya Liao, Qianxi Zhao, Huizi Zhang, Toru Nohgi, Jun Kameoka   +5 more
wiley   +1 more source

Saponins Derived from Chinese Medicinal Materials in Hyperuricemia and Gout: Therapeutic Mechanisms and Emerging Perspectives. [PDF]

Molecules
Wang Z, Chen Y, Li T, Hu Y, Li L.
europepmc   +1 more source

Plant‐Derived Probiotics From Fermented Foods: Current Evidence on Antiviral Mechanisms and Gut–Lung Axis Modulation

Food Frontiers, Volume 7, Issue 6, November 2026.
Plant‐derived probiotics from fermented foods exert anti‐respiratory virus effects via immune regulation, antiviral metabolites, and gut–lung axis, highlighting their advantages, key technologies, and application prospects. ABSTRACT Respiratory viral infections represent a major global public health threat, causing widespread morbidity, mortality, and ...
Yinghao Xing, Yaoyuan Hu, Yingying Ma, Peng Yao, Jingjing Jiang, Jiao Guo, Shuangmei Liu   +6 more
wiley   +1 more source

Phragmites Communis (Lu Gen) Alleviates Hyperuricemia via Xanthine Oxidase Inhibition and Gut-Microbiota-Mediated Metabolite Urate Transporter Regulation. [PDF]

Pharmaceuticals (Basel)
Saleem A, Walayat B, Xue Q, Ansari I, Wei X, Li M.   +5 more
europepmc   +1 more source

Dietary Interventions May Mitigate Health Risks of Per‐ and Polyfluoroalkyl Substances (PFAS) Exposure Through Modulation of the Gut Microbiota: A Review

Food Frontiers, Volume 7, Issue 6, November 2026.
Dietary interventions, including probiotics, prebiotics, and synbiotics, may modulate gut microbiota to regulate PFAS accumulation and elimination. Specific microbial taxa facilitate PFAS removal through adsorption and bioaccumulation, potentially reducing internal PFAS burden and mitigating PFAS‐related health risks.
Jiahui Xia, Xueqing Li, Mingluan Xing, Huixia Niu, Lizhi Wu, Xin Gong, Longxiao Liu, Zhijian Chen, Xiaoming Lou, Pengcheng Tu   +9 more
wiley   +1 more source